Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC.24: Preventing Chemotherapy-Related Heart Damage in Patients with Breast Cancer and Lymphoma: PROACT
Author(s): David Austin Added: 1 year ago
ACC.24 — We are joined onsite by Dr David Austin (South Tees Hospitals NHS Foundation Trust, UK) to discuss the findings from the PROACT trial (NCT03265574).Anthracyclines used in the treatment of breast cancer cause damage to the muscle cells in the heart, resulting in cardiotoxicity.PROACT is a phase III randomised superiority trial of enalapril for the prevention of anthracycline-induced… View more

CV Disease in Special Populations
Thomas Gilpin
Job title: Interventional Cardiology Research Fellow
Personal History Dr Thomas Gilpin is a British cardiologist. He is an Interventional Cardiology Research Fellow at the University Hospital Southampton NHS Foundation Trust. Academic History From 2008 to 2013, he attended Cardiff University where he studied Medicine.1 In 2020, Dr Gilpin started work on a PhD in Medicine, Human Development and Health at the University of Southampton… View more
Telomere Biology in Cardiovascular Disease
Author(s): Xian Wen Tan , Alan Yean Yip Fong , Siaw San Hwang Added: 2 years ago

Prevention & Chronic Conditions
Molecular Mechanisms of the Failing Heart: A Fatal Regression?
Author(s): Manami Katoh , Jin Komuro , Shunsuke Inoue , et al Added: 1 year ago

Heart Failure
Job title: Professor of Cardiology
Job title: Medical Scientist, Department of Gene and Cell Research
Sergey Kozhukhov
Research Area(s) / Expertise:

Cardio-oncology

Heart Failure

MI/ACS

Atrial Fibrillation

 Job title: Director of the Cardio-Oncology Center and Head of Clinical Pharmacology and Cardio-Oncology Department
Dr Sergey Kozhukhov is the founder and Director of the Cardio-Oncology Center and Head of Clinical Pharmacology and Cardio-Oncology Department at Strazhesko Institute of Cardiology, Kyiv, UA.His practice focuses on diagnosing and treating cardiovascular complications in patients with active cancer and his research focuses on studying early biomarkers of myocardial damage. Dr Kozhukhov has… View more
Job title: Professor of Cardiovascular Imaging and Cardiologist
Prof Robin Nijveldt is Professor of Cardiovascular Imaging and Cardiologist at the Radboud University Medical Center in Nijmegen, NL and connected to the Radboud Institute for Health Sciences. He works at the department of Cardiology and focusses on the Vascular damage research theme, with a special interest in Cardiovascular Magnetic Resonance imaging, CT and echocardiography, and in close… View more
TTR Therapies Show Delayed Mortality Benefit in ATTR-CM
Added: 3 weeks ago Source:  Radcliffe Cardiology
Therapies for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), including transthyretin (TTR) stabilisers and silencers, have demonstrated a mortality benefit in randomised trials. However, the timing of this benefit has been a subject of debate. A new analysis of three major outcomes trials has evaluated this time course, revealing a consistent pattern across different treatments… View more

Heart Failure
Job title: Chief Science Officer